Edition:
United Kingdom

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

2.84USD
16 Feb 2018
Change (% chg)

$-0.09 (-3.07%)
Prev Close
$2.93
Open
$3.00
Day's High
$3.03
Day's Low
$2.80
Volume
9,740
Avg. Vol
48,142
52-wk High
$6.60
52-wk Low
$1.64

Chart for

About

Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $7.39
Shares Outstanding(Mil.): 3.34
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Bioblast Pharma reports Q3 loss per share $0.32

* Bioblast Pharma reports third quarter 2017 financial results

02 Nov 2017

BRIEF-Bioblast announces effectiveness of five to one reverse split

* Bioblast announces effectiveness of five to one reverse split

25 Sep 2017

Earnings vs. Estimates